<h1>Claims About Robotic-Assisted 'Gold Knee' Implants Require Evidence, Clear Risk Disclosure, Regulatory Clearance, and Substantiated Advertising</h1> Press materials touting robotic-assisted joint replacements and a titanium-nitride 'Gold Knee' implant raise legal considerations: representations of superior safety, durability, and faster recovery may trigger consumer protection and medical advertising scrutiny if unsupported by robust clinical evidence or regulatory approvals. Providers and manufacturers should ensure device regulatory clearance, accurate outcome data, and transparent disclosure of risks, alternatives, and any conflicts of interest to satisfy informed-consent and professional-liability standards. Patient testimonials and claims of allergy safety warrant substantiation to avoid false-advertising or product-liability exposure. Hospitals must document indications for surgery and postoperative outcomes to mitigate malpractice and compliance risks.